Page last updated: 2024-08-24

irinotecan and Cancer of Penis

irinotecan has been researched along with Cancer of Penis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bargain, A; Boulaire, JL; Ketata, S; Soulimane, B	1
Bodrogi, I; Collette, L; Kerst, JM; Leahy, M; Marréaud, S; Oliver, RDT; Skoneczna, I; Theodore, C; Ven, K	1

Reviews

1 review(s) available for irinotecan and Cancer of Penis

Article	Year
Metachronous metastasis to the penis from a rectal adenocarcinoma. Clinical colorectal cancer, 2007, Volume: 6, Issue:9 Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Humans; Immunohistochemistry; Irinotecan; Male; Middle Aged; Palliative Care; Penile Neoplasms; Prognosis; Rectal Neoplasms	2007

Article

Year

Metachronous metastasis to the penis from a rectal adenocarcinoma.

Clinical colorectal cancer, 2007, Volume: 6, Issue:9

Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Humans; Immunohistochemistry; Irinotecan; Male; Middle Aged; Palliative Care; Penile Neoplasms; Prognosis; Rectal Neoplasms

2007

Trials

1 trial(s) available for irinotecan and Cancer of Penis

Article	Year
A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Feasibility Studies; Follow-Up Studies; Humans; Irinotecan; Male; Middle Aged; Penile Neoplasms; Time Factors; Treatment Outcome	2008

Article

Year

A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992).

Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:7

Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Feasibility Studies; Follow-Up Studies; Humans; Irinotecan; Male; Middle Aged; Penile Neoplasms; Time Factors; Treatment Outcome

2008